Oxford Nanopore Technologies has announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its PromethION product range.
ThePromethION 2 Integrated sets a new standard for convenience and efficiency in DNA, RNA, and cDNA sequencing. With its onboard computing capabilities, the self-contained device is bringing high-quality sequencing to a wider range of research and academic labs.
Engineered with robust and powerful onboard computing capabilities, the P2i facilitates real-time base calling and post run analysis directly within the device, eliminating the dependency on external computing resources.
“With the launch of the P2i, Oxford Nanopore is heralding a new era of sequencing technology, offering a fully integrated, plug-and-play device that opens up unparalleled possibilities in both research and applied markets. Following the success of the P2 Solo, we are pleased to be able to offer a fully integrated alternative to those researchers who want the same high-quality nanopore sequencing to work straight out of the box.” – Gordon Sanghera, CEO of Oxford Nanopore
The P2i Early Access is being run in key global territories including Europe, USA, Canada, Japan and parts of Middle East and Asia. There may be some country restrictions during Early Access. For more information, click here.
